Study S001072

The Effect of Liraglutide on Pregnancy Rates in Obese Women With PCOS Undergoing in Vitro Fertilization: a Pilot Randomized Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03353948
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 30
Start: 2014-09-01
Primary completion: 2016-05-31
Lead sponsor: University Medical Centre Ljubljana
Conditions: Polycystic Ovary Syndrome; Obesity; Infertility, Female
Interventions: DRUG:MET; DRUG:COMBI
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

IVF pregnancy rates [14 days]
BMI [Patient's BMI was measured at the beginning and every four weeks during 12 weeks of clinical trial. ]]
Cumulative pregnancy rates [The pregnancies were collected by phone interview after one year]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0018103	Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin. Jensterle Sever M, European journal of endocrinology	2014	Randomized trial	PMID 24362411 DOI	registry reference BACKGROUND:24362411